期刊文献+

柴胡疏肝散加减对类风湿关节炎伴随抑郁症治疗的临床观察 被引量:5

Clinical observation on the treatment of depressive symptoms and rheumatoid arthritis with Chaihu Shugan Powder
下载PDF
导出
摘要 目的:观察中药柴胡疏肝散加减对伴有抑郁症的类风湿关节炎患者抑郁状态改善和生命质量提高的作用。方法:对68例患者抑郁症治疗前后的评定,随机分成对照组、观察组两组,对照组在抗风湿基础治疗上联合氟罗西汀,观察组在抗风湿基础治疗上联合中药柴胡疏肝散加减,进行临床对照观察。疗程均为2月。采用生活质量表、汉密尔顿抑郁量表(HAMD)、焦虑自评量表(SAS)分别观察两组的临床疗效和症候的改善情况。结果:经2个月治疗后两组患者的生活质量表、汉密尔顿抑郁量表(HAMD)、焦虑自评量表(SAS)都有改善(P<0.01),差异具有统计学意义。结论:中药治疗类风湿关节炎伴随抑郁症是有效且患者乐于接受的。 Objective :To observe the clinical efficacy of Chaihu Shugan Powder on depressive symptoms and rheumatoid arthritis .Methods:68 patients with depressive symptoms were randomly divided into 2 groups:34 cases in control group treated with paroxetine ;34 cases in treatment group treated with oral Chaihu Shugan Powder(plus-minus).Patients were regularly treated every day.After 2 months, HAMD.SAS mark were exam to evaluated the clinical efficacy and improvement of symptoms.Results: After treatment.scores of HAMD.SAS mark decreased (P〈0.01)and the changes were more significant in treatment group.Conclusion: Chaihu Shugan Powder can improve the clinical symptoms of depressive symptoms and rheumatoid arthritis has more advantages.
作者 陈佩珏
出处 《内蒙古中医药》 2015年第2期1-2,共2页 Inner Mongolia Journal of Traditional Chinese Medicine
关键词 柴胡疏肝散 类风湿关节炎 抑郁症 Depressive symptoms and rheumatoid arthritis Chaihu Shugan powder
  • 相关文献

参考文献5

二级参考文献31

  • 1费立鹏 Henderson G.医学社会科学的临床应用:医学社会科学在临床科研的设计和评价中的使用[M].上海临床流行病中心,1997..
  • 2费立鹏,医学社会科学的临床应用.医学社会科学在临床科研的设计和评价中的使用,1997年
  • 3钟南山;陆再英.内科学[M]北京:人民卫生出版社,2009848-851.
  • 4McInnes I B,Schett G. The pathogenesis of rheumatoid arthritis[J].New England Journal of Medicine,2011,(23):2205-2219.
  • 5菲尔斯坦.凯利风湿病学[M]北京:北京大学医学出版社,20111185-1206.
  • 6LEADER. Anti-inflammatory mechanism of methotrexate inrheumatoid arthritis[J].Annals of the Rheumatic Diseases,2001.729-735.
  • 7Fiehn C. Rheumatoid arthritis:milestones in classification and treatment[J].Deutsche Medizinische Wochenschrift,2011.203-205.
  • 8Ishaq M,Muhammad JS,Hameed K. Leflunomide or methotrexate:Comparison of clinical efficacy and safety in low socio-economic rheumatoid arthritis patient[J].Mod Rheumatol K,2011,(04):375-380.
  • 9Reddy SV,Wanchu A,Khullar M. Leflunomide reduces nitricoxide production in patients with active rheumatoid arthritis[J].International Journal of Immunopharmacology,2005,(06):1085-1090.
  • 10Larsen A,Kvien TK,Schattenkirchner M. Slowing of disease progression in rheumatoid arthritis during longterm treatment with leflunomide sulfasalazin[J].Scandinavian Journal of Rheumatology,2001,(03):135-142.

共引文献111

同被引文献110

引证文献5

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部